SARAH PEDERSON: Open Payments
NPI 1407313968 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 21 payments from 10 companies in 2025. Trend: 2023 $866 · 2024 $1,132 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $83 |
| Boston Scientific Corporation | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 2 | $37 |
| PFIZER INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Solventum Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
Products named: Wegovy, LEQVIO, Varithena Administration Pack, REPATHA, VYNDAQEL, VERQUVO, WATCHMAN FLX, V.A.C. VERAFLO.
Industry payments across AR — which companies pay providers there.
